ANDRX PHARMACEUTICALS, LLC – Trademark Portfolio
Entity Type: 16
ANDRX PHARMACEUTICALS, LLC holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CYCLAFEM, PREVIFEM, TRI-PREVIFEM, and CYCLAFEM 7/7/7. The owner is based in DAVIE, FL.
4955 ORANGE DRIVE
DAVIE, FL 33314
Showing of trademarks Trademarks
Trademark Classifications
ANDRX PHARMACEUTICALS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ANDRX PHARMACEUTICALS, LLC have?
ANDRX PHARMACEUTICALS, LLC has 24 U.S. trademarks filed with the USPTO. Of these, 4 registered, 11 abandoned, 9 cancelled.
What trademark classes does ANDRX PHARMACEUTICALS, LLC file in?
ANDRX PHARMACEUTICALS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ANDRX PHARMACEUTICALS, LLC's most well-known trademarks?
ANDRX PHARMACEUTICALS, LLC's registered trademark portfolio includes well-known marks such as CYCLAFEM, PREVIFEM, TRI-PREVIFEM, and CYCLAFEM 7/7/7. These are among 4 currently registered trademarks in the portfolio.
What is ANDRX PHARMACEUTICALS, LLC's trademark registration success rate?
ANDRX PHARMACEUTICALS, LLC has a 17% trademark registration rate, with 4 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.